View source for 20240019419. MICROFLUIDIC-BASED BLADDER CANCER MIMIC AND USE THEREOF simplified abstract (CHUNG ANG UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION)

=MICROFLUIDIC-BASED BLADDER CANCER MIMIC AND USE THEREOF=


==Organization Name==

[[:Category:CHUNG ANG UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION|CHUNG ANG UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION]]


[[Category:CHUNG ANG UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION]]

==Inventor(s)==

[[:Category:In Ho Chang of Seoul (KR)|In Ho Chang of Seoul (KR)]][[Category:In Ho Chang of Seoul (KR)]]

[[:Category:Joong Yull Park of Seoul (KR)|Joong Yull Park of Seoul (KR)]][[Category:Joong Yull Park of Seoul (KR)]]

[[:Category:Se Young Choi of Seoul (KR)|Se Young Choi of Seoul (KR)]][[Category:Se Young Choi of Seoul (KR)]]

==MICROFLUIDIC-BASED BLADDER CANCER MIMIC AND USE THEREOF - A simplified explanation of the abstract==


This abstract first appeared for US patent application 20240019419 titled 'MICROFLUIDIC-BASED BLADDER CANCER MIMIC AND USE THEREOF

==Simplified Explanation==

The abstract describes a patent application for a microfluidic bladder cancer mimic and its use in screening bladder cancer treatment substances. The bladder cancer mimic is produced using 3D printing, which allows for a more accurate representation of in vivo environments compared to conventional two-dimensional cell models. It is also simpler to produce than animal models. The lab-on-a-chip, which includes the bladder cancer mimic, can be used to develop anticancer therapeutic agents and patient-specific therapeutic agents using patient-derived bladder cancer cells.

* The patent application describes a microfluidic bladder cancer mimic produced through 3D printing.
* The mimic provides a more accurate representation of in vivo environments compared to conventional two-dimensional cell models.
* The mimic is simpler to produce than animal models.
* The lab-on-a-chip, including the bladder cancer mimic, can be used for screening bladder cancer treatment substances.
* The technology can aid in the development of anticancer therapeutic agents.
* The technology can be used to develop patient-specific therapeutic agents using patient-derived bladder cancer cells.

== Potential Applications ==
* Screening bladder cancer treatment substances
* Development of anticancer therapeutic agents
* Development of patient-specific therapeutic agents

== Problems Solved ==
* Lack of accurate representation of in vivo environments in conventional two-dimensional cell models
* Complexity and limitations of animal models for bladder cancer research

== Benefits ==
* More accurate representation of bladder cancer in vivo environments
* Simplified production process compared to animal models
* Potential for personalized medicine using patient-derived bladder cancer cells


==Original Abstract Submitted==

a microfluidic bladder cancer mimic and the use thereof is provided. the bladder cancer mimic is produced through 3d printing, which may more accurately reflect in vivo environments than conventional two-dimensional cell models and may be more simply produced than animal models. a method of screening bladder cancer treatment substances using a lab-on-a-chip including the bladder cancer mimic that may be used for the development of anticancer therapeutic agents and may also be used to develop patient-specific therapeutic agents by using patient-derived bladder cancer cells.



[[Category:G01N33/50]]
[[Category:C12N5/071]]
[[Category:C12M3/00]]
[[Category:B01L3/00]]